Cronos (CRON) Shares Outstanding (Weighted Average) (2016 - 2026)

Cronos (CRON) recorded quarterly Shares Outstanding (Weighted Average) of $379.4 million in Q1 2026, down 1.07% quarter-over-quarter from $383.5 million in Q4 2025, and down 0.94% on a YoY basis from $383.0 million in Q1 2025.

Cronos (CRON) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends

Cronos' Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $379.4 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) fell 0.94% year-over-year to $379.4 million; the TTM figure through Mar 2026 stood at $379.4 million (down 0.94% YoY), while the FY2025 annual figure was $383.5 million, changed 0.37% from the prior year.
  • Shares Outstanding (Weighted Average) was $379.4 million for Q1 2026 at Cronos, down from $383.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $385.3 million in Q2 2025 to a low of $375.0 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $380.2 million across 5 years, with a median of $381.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) gained 3.31% in 2022, then slipped 0.94% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $377.0 million in 2022, then increased by 1.06% to $381.0 million in 2023, then grew by 0.29% to $382.1 million in 2024, then increased by 0.37% to $383.5 million in 2025, then decreased by 1.07% to $379.4 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $379.4 million (Q1 2026), $383.5 million (Q4 2025), and $385.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Cronos 1.06 Bn 292.44 Mn 19.15 Mn 379.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 379.37 Mn
Dec 31, 2025 383.47 Mn
Jun 30, 2025 385.31 Mn
Mar 31, 2025 382.96 Mn
Dec 31, 2024 382.06 Mn
Sep 30, 2024 382.29 Mn
Dec 31, 2023 380.96 Mn
Dec 31, 2022 376.96 Mn
Sep 30, 2022 378.11 Mn
Jun 30, 2022 375.53 Mn
Mar 31, 2022 375.02 Mn
Dec 31, 2021 370.39 Mn
Sep 30, 2021 372.46 Mn
Jun 30, 2021 367.39 Mn
Mar 31, 2021 363.01 Mn
Dec 31, 2020 351.58 Mn
Sep 30, 2020 350.29 Mn
Jun 30, 2020 348.95 Mn
Mar 31, 2020 348.82 Mn
Sep 30, 2019 338.96 Mn